BioCentury
ARTICLE | Company News

Otsuka Pharmaceutical sales and marketing update

May 23, 2016 7:00 AM UTC

Otsuka’s Avanir Pharmaceuticals Inc. subsidiary launched Onzetra Xsail sumatriptan nasal powder in the U.S. to treat acute migraine with or without aura in adults. The wholesale acquisition cost (WA...